We look forward to advancing ribupatide globally with the goal of broadening treatment options for people living with obesityespecially those with high BMIs and greater disease burden, where the unmet need remains substantial. Phase 2 Clinical Trial of Ribupatide Oral in Adults Living with Obesity Hengruis Phase 2 clinical trial of once-daily ribupatide oral (also known as HRS9531 pill and KAI-9531-T) in China met its primary endpoint, achieving superior weight loss with ribupatide (10 mg, 25 mg, and 50 mg) compared to placebo at Week 26
Overall, the GLP-1RA group had a 10% decrease in depression risk compared to the DPP4i group
The affected enzymes, ERK1/2, along with their downstream targets, including c-Fos, c-Jun, and Egr-1, are believed to play significant roles in cell growth, migration, and angiogenesis, which is the development of new blood vessels
Marcia US 1 review Aug 7, 2025 It was simple, easy, and the communication is great
Sleep & longevity CJC/Ipamorelin and MOTS-c are used by patients focused on deep sleep quality and long-term metabolic health
